Keryx Financial Statements From 2010 to 2024
Keryx Biopharmaceutica financial statements provide useful quarterly and yearly information to potential Keryx Biopharmaceuticals investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Keryx Biopharmaceutica financial statements helps investors assess Keryx Biopharmaceutica's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Keryx Biopharmaceutica's valuation are summarized below:Keryx Biopharmaceuticals does not presently have any fundamental ratios for analysis.
This module can also supplement various Keryx Biopharmaceutica Technical models . Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Check Keryx Biopharmaceutica financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Keryx main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Keryx financial statements analysis is a perfect complement when working with Keryx Biopharmaceutica Valuation or Volatility modules.
Keryx |
Keryx Biopharmaceuticals Company Return On Asset Analysis
Keryx Biopharmaceutica's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Keryx Biopharmaceutica Return On Asset | -135.06 |
Most of Keryx Biopharmaceutica's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Keryx Biopharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Keryx Biopharmaceuticals has a Return On Asset of -135.0618. This is much higher than that of the sector and notably higher than that of the Return On Asset industry. The return on asset for all United States stocks is notably higher than that of the company.
Keryx Biopharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Keryx Biopharmaceutica's current stock value. Our valuation model uses many indicators to compare Keryx Biopharmaceutica value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Keryx Biopharmaceutica competition to find correlations between indicators driving Keryx Biopharmaceutica's intrinsic value. More Info.Keryx Biopharmaceuticals is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Keryx Biopharmaceutica by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Keryx Biopharmaceutica's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Keryx Biopharmaceutica's earnings, one of the primary drivers of an investment's value.Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Keryx Biopharmaceutica in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Keryx Biopharmaceutica's short interest history, or implied volatility extrapolated from Keryx Biopharmaceutica options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Keryx Stock
If you are still planning to invest in Keryx Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Keryx Biopharmaceutica's history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |